CHOSA (CHOSA) | Spotlight

Chosa Oncology, Danish -Swedish biotechnology company, has developed the iCIP platform, which includes a liposomal formulation of cisplatin (LiPlaCis) and the companion diagnostic (DRP) tool detecting patients who benefits the most of the cisplatin treatment. The recently achieved clinical phase 2b results mean that the Company is now gearing up the business development activities to find partners for partnership or trade deal.

Quotes for CHOSA Oncology AB

Right Now

+/-: -0.07
%: −10,53%
Latest: 0.595
High: 0.67
Low: 0.595
Volume: 1 308
Turnover (SEK): 871
Market Value (MSEK): 42,2
Time (Latest trade): 2025-07-07 16:04

Board

CEO

Peter Buhl

Chairperson of the Board

Ingrid Atteryd Heiman

Board

Claus Frisenberg Pedersen
Fred Hirsch
Morten Myrhøj
Neil Goldsmith
Ulla Hald Buhl

Articles of association

News

2025-07-01 16:19:56 CHOSA förlänger tidplan för insamling av biopsier inför publicering från SPLENDOUR-studien
2025-07-01 16:19:56 CHOSA extends the timeline for biopsy collection prior to publication from the SPLENDOUR study
2025-06-27 15:48:47 Chosa Oncology offentliggör utfall i företrädesemission
2025-06-27 15:48:47 Chosa Oncology announces outcome in rights issue
2025-06-25 12:00:00 Sista teckningsdag i Chosas teckningsperiod

News agencies

2025-07-01 16:33:27 Finwire: Chosa Oncology förlänger tidplan för insamling av biopsier
2025-06-27 16:05:40 Finwire: Chosa Oncologys företrädesemission tecknades till drygt 9 procent
2025-06-25 09:23:09 Finwire: Chosa Oncology lämnar in ny patentansökan för utökad användning av Platin-DRP
2025-06-09 06:41:00 Finwire: Chosa Oncology handlas i dag på Spotlight exklusive teckningsrätt i företrädesemission
2025-06-02 09:08:00 Finwire: Chosa Oncology genomför riktad emission och företrädesemission om totalt 20 miljoner kronor

Analysis

Largest Owners

Name	Capital %	Votes %	Date
Buhl Krone Holding ApS	22,04	22,04	2025-03-27
Claus Frisenberg Pedersen	11,68	11,68	2023-01-18
IPO Nordic Fund A/S	8,36	8,36	2025-03-27
Smerud Medical Research International AS	7,48	7,48	2025-03-27
Rutger Arnhult	5,48	5,48	2025-03-27
Nels Holding Aps	4,00	4,00	2025-03-27
Lh\|Lh Invest Aps	2,97	2,97	2025-03-27
Karsgaard Holding Ostervra Aps	2,36	2,36	2025-03-27
Sorgenfri Nr. 1 A/S	2,17	2,17	2025-03-27
Rq Solutions Aps	1,87	1,87	2025-03-27

** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

CHOSA Oncology AB